| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | DBV TECHNOLOGIES S A | 30,000 | 1,057,000 | 0.25% | Call | |
| 52 | VERSARTIS INC | 49,100 | 1,048,000 | 0.25% | Put | |
| 53 | ADVISORY BRD CO COM | 21,300 | 997,000 | 0.24% | ||
| 54 | XBIOTECH INC | 60,000 | 989,000 | 0.23% | Call | |
| 55 | Progenics Pharmaceuticals Inc | 100,000 | 944,000 | 0.22% | ||
| 56 | ROCKWELL MED INC | 140,000 | 876,000 | 0.21% | Put | |
| 57 | CONCERT PHARMACEUTICALS INCORPORATED | 49,051 | 837,000 | 0.20% | ||
| 58 | INVITAE CORP | 70,000 | 774,000 | 0.18% | Put | |
| 59 | AEHR TEST SYSTEMS | 122,000 | 587,000 | 0.14% | ||
| 60 | INVITAE CORP | 50,000 | 553,000 | 0.13% | Call | |
| 61 | OMEROS CORP | 30,000 | 454,000 | 0.11% | Call | |
| 62 | XBIOTECH INC | 20,000 | 330,000 | 0.08% | Put | |
| 63 | LION BIOTECHNOLOGIES INC COM | 40,000 | 298,000 | 0.07% | Call | |
| 64 | QUOTIENT LTD | 18,900 | 132,000 | 0.03% | ||
| 65 | ONCOBIOLOGICS INC | 29,082 | 78,000 | 0.02% | ||
| 66 | ONCOBIOLOGICS INC - WARRANT A | 96,833 | 77,000 | 0.02% | ||
| 67 | ONCOBIOLOGICS INC - WARRANT B | 96,833 | 48,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001493152-17-005200, filed 2017.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
